Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/688
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Ketone doai > Benzene ring containing > C=o bonded directly to benzene ring (e.g., acetophenone, etc.)
Description: Subject matter wherein is bonded directly to the benzene ring.

Sub-classes under this class:

Class Number Class Name Patents
514/689 Oxygen single bonded to carbon 77

Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
8658161 Solubilized CoQ-10 Feb. 25, 2014
8642660 Method for altering the lifespan of eukaryotic organisms Feb. 4, 2014
8617541 Solubilized CoQ-10 Dec. 31, 2013
8563615 Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders Oct. 22, 2013
8506859 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene Aug. 13, 2013
8445437 Treatment and prevention of cardiovascular disease using mast cell stabilizers May. 21, 2013
8147826 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene Apr. 3, 2012
8124072 Solubilized CoQ-10 Feb. 28, 2012
8105583 Solubilized CoQ-10 Jan. 31, 2012
8067464 Compositions and methods using apocynin compounds and nitric oxide donors Nov. 29, 2011
8063108 Method for modulating microbial quorum sensing Nov. 22, 2011
8048905 Tetrazole-substituted arylamides as P2X.sub.3 and P2X.sub.2/3 antagonists Nov. 1, 2011
7579380 Modified release formulations of a bupropion salt Aug. 25, 2009
7384646 Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same Jun. 10, 2008
7348363 Method of controlling zoological and aquatic plant growth Mar. 25, 2008
7064124 NF-.kappa.B inhibitor containing substituted benzoic acid derivative as active ingredient Jun. 20, 2006
6984389 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Jan. 10, 2006
6943196 NF-.kappa.B inhibitor comprising phenylmethyl benzoquinone as the active ingredient Sep. 13, 2005
6790463 Uses of targeted oxidative therapeutic formulation in arteriosclerosis Sep. 14, 2004
6677376 Non-peptidic cyclophilin binding compounds and their use Jan. 13, 2004
6673788 Electrophilic ketones for the treatment of herpesvirus infections Jan. 6, 2004
6670349 Composition & method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone &/or a ubiquinone Dec. 30, 2003
6562332 Attractants of beneficial insects May. 13, 2003
6498195 Use of 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4'-hydroxyphenyl) as an anticarcinogenic agent Dec. 24, 2002
6492429 Composition for the treatment of osteoarthritis Dec. 10, 2002
6491930 Stable cosmetic formulation containing butylmethoxydibenzoylmethane Dec. 10, 2002
6479554 Immunotherapeutic agents Nov. 12, 2002
6458847 Method for screening for drugs useful in inhibition of polymerization of a.beta. and tau peptides Oct. 1, 2002
6455578 Aromatic derivatives and iron complexes thereof for the use as normalizing agents of the iron level Sep. 24, 2002
6436423 Product and method for improving avian health Aug. 20, 2002
6407137 Dopamine analog amide Jun. 18, 2002
6331555 Treatment of platelet derived growth factor related disorders such as cancers Dec. 18, 2001
6291533 Dietary supplements for each specific blood type Sep. 18, 2001
6258854 Ketone precursors for organoleptic compounds Jul. 10, 2001
6258836 Dopamine analog amide Jul. 10, 2001
6177474 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same Jan. 23, 2001
6177472 Regulation of alzheimer's disease proteins and uses thereof Jan. 23, 2001
6133305 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity Oct. 17, 2000
6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone Jul. 11, 2000
6087402 Foam cleaning compositions Jul. 11, 2000
6080792 Foam cleaning compositions Jun. 27, 2000
5994392 Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid Nov. 30, 1999
5910311 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it Jun. 8, 1999
5906992 Foam cleaning compositions May. 25, 1999
5866569 Naphthalenedione nitric oxide synthase (NOS) inhibitors Feb. 2, 1999
5824665 Reduction of hair growth Oct. 20, 1998
5763495 Widely-bridged alcohol polyethoxylates and their use Jun. 9, 1998
5716995 Anti-osteopathic composition Feb. 10, 1998
5618547 Control of ectoparasites Apr. 8, 1997
5508275 Lipid-selective antioxidants and their preparation and use Apr. 16, 1996

1 2

  Recently Added Patents
Demand based power allocation
Cardiac function management integrating cardiac contractility modulation
Method and apparatus for representing sensory effects and computer readable recording medium storing user sensory preference metadata
Network traffic demotion
Secure provisioning of a portable device using a representation of a key
Churn prediction and management system
Engineered nucleic acids encoding a modified erythropoietin and their expression
  Randomly Featured Patents
Adjustable hurdle
Surface treatment method and coating method of polyamide resin molded articles
Strains of Escherichia coli which produce isoleucine or valine and a method for their production
Broaching tool
Video conferencing with adaptive client-controlled resource utilization
Packet switching system
Trench forming method and structure
Photoresist and polymer removal by UV laser aqueous oxidant
Typed data graph visualization system in three dimensions
Method of manufacturing a junction field effect transistor